YORVIPATH was granted an Orphan Drug Designation and assessed through the TGA’s Priority Review pathway. It is the first and only medicine to be listed on the Australian Register of Therapeutic ...

With TGA Smart-Seal Pans, we're introducing a groundbreaking solution that delivers reliable, accurate TGA data at a lower cost within a traditional laboratory environment." Designed to be ...

The Super Bowl logo has become more of a talking point among NFL fans over the last few seasons. Part of the reason for that is a conspiracy theory that the colors of the Super Bowl logo determine ...

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

The New Discovery TGA 5500, TGA 550, and TGA 55 feature a progressive system design resulting in unprecedented performance in sensitivity, temperature control, atmosphere control, and baseline drift.

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

TA Instruments is the world’s leading supplier of TGA instruments. The TGA 550 not only outperforms competitive top tier systems, but also gives users the flexibility to add advanced features ...

But the visual representation of this industry disruptor is not a swirling black-void logo à la OpenAI, or even a robot. Instead, it’s a friendly blue whale. This diverges from branding trends ...

Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been granted marketing ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

On Monday, three logos were revealed to the public, one for each potential nickname, but NHL fans weren't particularly impressed by the latest round of options. Much of the criticism was focused ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...